Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

AIMS: This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD). Coronary heart disease is prevalent among AF patients and limits antiarrhythmic drug use because of their potential...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pisters, Ron, Hohnloser, Stefan H., Connolly, Stuart J., Torp-Pedersen, Christian, Naditch-Brûlé, Lisa, Page, Richard L., Crijns, Harry J.G.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905706/
https://ncbi.nlm.nih.gov/pubmed/24072451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/eut293
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky